Financial Report

Stories in this section:
Medifast 3rd Quarter Revenue Up 79%
Third Quarter Results
November Stock Watch

Third Quarter Results

Herbalife

Herbalife Ltd. (HLF-NYSE) recently reported third-quarter net sales of $476.4 million, an increase of 18.8 percent compared to the same period in 2005. This record performance was largely attributable to increases in the company's two largest markets, Mexico and the United States, which reported net sales growth of 66 percent and 24.7 percent, respectively, versus the third quarter of 2005. The company's Chief Executive Officer, Michael O. Johnson, said, "I am pleased with the strong sales growth we have generated in our top markets. We believe our innovative distributor business methods, combined with engaged leadership and high-quality products, will continue to serve as the primary sales drivers in our existing markets."

During the third quarter of 2006, new distributor supervisors increased 18.9 percent versus the same period in 2005. Total supervisors, as of Sept. 30, 2006, increased 23.8 percent versus 2005, and the company's President's Team increased 17 percent year-over-year to 958 members.

For the quarter ending Sept. 30, 2006, the company reported net income of $26.5 million, or $0.36 per diluted share, compared with $27.1 million, or $0.37 per diluted share in the third quarter of 2005.

The company also continued executing its China strategy by opening five new stores in three additional provinces, bringing the total to 33 stores in 20 provinces as of Sept. 30, 2006. "I am pleased with our performance in China," said Herbalife President and COO Greg Probert. "The results we generated through the third quarter were in line with our expectations and, although we are still awaiting approval for our direct selling license, we remain optimistic about our long-term prospects in this important market."

Herbalife is a global network marketing company that sells weight-management nutritional supplements and personal-care products intended to support a healthy lifestyle. Herbalife products are sold in 62 countries through a network of more than 1 million independent distributors.

Nu Skin

Nu Skin Enterprises Inc. (NUS-NYSE) recently reported third-quarter revenue of $276.3 million and earnings per share were $0.19, both in line with company guidance.

For the quarter ended Sept. 30, 2006, Nu Skin Enterprises' revenue was $276.3 million, down 8 percent from $290.8 million for the prior-year period. Net income and earnings per share for the quarter were down 26 percent to $13.2 million and $0.19, respectively, compared to net income of $17.7 million and earnings per share of $0.25 for the same period in 2005. Revenue for the quarter was negatively affected by 1 percent from foreign currency fluctuations.

Nu Skin Enterprises Inc. is a global direct selling company operating in 44 markets throughout Asia, the Americas and Europe. The company markets premium-quality personal-care products under the Nu Skin® brand, science-based nutritional supplements under the Pharmanex® brand, and technology-based products and services under the Big Planet® brand.

Relìv

Relìv International Inc. (RELV-Nasdaq) recently reported a 4.3 percent increase in net sales and an 8.1 percent increase in net income for the third quarter of 2006 compared to the same period last year.

Net sales were $29.8 million for the third quarter, compared to $28.6 million in the year-ago quarter. Net income rose to $1.80 million, or $0.11 diluted earnings per share, compared to net income of $1.67 million, or $0.10 diluted earnings per share, in the third quarter of 2005.

"We said we expected to return to growth in net sales and net income after the second quarter, and we're pleased we accomplished that objective," said Robert L. Montgomery, Chairman, President and Chief Executive Officer. "Our goal is to return to double-digit growth."

Relìv International Inc., based in suburban St. Louis, develops, manufactures and markets a proprietary line of nutritional supplements. Relìv sells its products through an international network marketing system of approximately 65,000 independent distributors.

RBC Life Sciences

RBC Life Sciences Inc. (RBCL OTC:BB) recently reported a 10 percent increase in net sales to $5,405,000 in the third quarter of 2006 compared to net sales of $4,915,000 in the same period of last year. The company's net earnings in the third quarter of 2006 were $80,000, or 0 cents per diluted share, compared to net earnings of $149,000, or 1 cent per diluted share, in the third quarter of 2005.

Clinton Howard, CEO, said, "The increase in net sales resulted from two factors: 1) continuing expansion of markets for our nutritional products outside the U.S. and 2) continuing growth of our domestic medical products business. While gross profit increased in 2006, pre-tax earnings in 2006 were reduced as a result of nonrecurring expenses related to our subsidiary in South Korea (RBC Korea).

"On Oct. 31, 2006, RBC sold RBC Korea to a private Korean corporation owned by the individual who served as CEO of RBC Korea. As part of the sale agreement, we granted the purchaser a five-year exclusive license to continue marketing RBC products in South Korea."

RBC Life Sciences manufactures high quality nutritional supplements through independent distributors in North America, and through foreign licensees who distribute RBC products in thirty four countries.

Mannatech

Mannatech Inc. (MTEX-Nasdaq) recently reported record earnings of $0.36 cents per diluted share for its third quarter 2006, up 13 percent from third quarter 2005 earnings of $0.32 per diluted share. Net income for the quarter reached a record $9.7 million with a net-profit ratio of 9.7 percent. The 1 point net-profit rate improvement versus prior year was partially due to a lower effective tax rate in the quarter. Pretax profit was $12.7 million for the quarter, compared to $13 million, down 2 percent versus prior year.

Total third-quarter net sales were $99.6 million, slightly below prior-year sales of $100.2 million. Total Mannatech independent associates and members grew to 536,000 as of Sept. 30, 2006, an increase of 14 percent compared with the same period of the prior year.

Mannatech Inc. is a global wellness-solutions provider that develops innovative, high-quality, proprietary nutritional supplements, topical and skincare products, and weight management products that are sold through approximately 536,0000 independent associates and members worldwide.

Tiens USA Tiens Biotech Group (USA) Inc. (Tiens USA), (TBV-Amex), announced revenue for the third quarter ended Sept. 30, 2006, of $19,187,748, compared to $19,126,809 for 2005, and an increase of 34 percent from revenue reported for the second quarter of 2006.

Third quarter net income was $8,435,264 compared to net income of $8,204,744 for 2005. Third quarter earnings per share were $0.12, with weighted average number of shares outstanding of 71,333,586 compared to $0.14, with the same weighted average number of shares outstanding for the comparable period of 2005.

Jinyuan Li, Chairman, President and CEO of Tiens USA, said, "In the third quarter, Tiens USA continued to increase the international demand for its nutrition supplements and personal care products and generated an improvement in sales in China compared to the second quarter. Although the direct selling regulatory environment in China is currently challenging, we are hopeful that our affiliate, Tianshi Engineering, will receive a direct selling license from the Chinese regulatory authorities in the near future."

Tiens Biotech Group (USA) Inc. conducts its main business operations through its 80 percent-owned subsidiary Tianjin Tianshi Biological Development Co., Ltd. (Biological), based in Tianjin, People's Republic of China. Biological primarily engages in the research, development, manufacturing and marketing of nutrition supplement products.

AMS Health Sciences

AMS Health Sciences Inc. (AMM-Amex) recently announced a net loss from continuing operations for the third quarter 2006 of $583,299, or $0.07 per common share, on 7.8 million shares outstanding. Results for the three months ended Sept. 30, 2006, including discontinued operations, was a net loss of $635,774 or $0.08 per common share, on 7.8 million shares outstanding. This compares to a net loss of $513,868, or $0.07 per common share, on 7.5 million shares outstanding in the third quarter of 2005. Sales totaled $2.3 million for the quarter compared to sales of $2.6 million for the quarter ended Sept. 30, 2005.

AMS Health Sciences Inc. sells more than 60 natural nutritional supplements, weight-management products and natural skincare products through independent distributors across the United States and Canada.

ACTIS

ACTIS Global Ventures Inc. (AGLV-OTC) recently reported consolidated net sales of $2,560,379 for the three months ended Sept. 30, 2006, an increase of 26 percent, from $2,035,035 in 2005. Gross profits for the three months ended Sept. 30, 2006, increased to $2,022,971 from $1,734,766 in 2005, representing an increase of 17 percent.

ACTIS Global Ventures Inc. formerly FemOne Inc. based in Carlsbad, Calif., markets and sells products through direct sales and direct response television. Its direct sales are generated through two divisions, BIOPRO Technology distributing Bioenergetics products in the United States, Canada, Australia, New Zealand and South Africa, and FemOne, distributing nutritional products in the United States and Canada. Second Quarter Results

CPAC

CPAC Inc. (CPAK-Nasdaq) recently reported net sales for the second quarter ended Sept. 30, 2006, increased 20.8 percent to $25.9 million, compared to $21.5 million for the same quarter last year (20.2 percent excluding the impact of foreign currency exchange). Net income for the quarter was $860,000, or $0.17 per diluted share, versus a net loss of $213,000 or $0.04 per diluted share, for the quarter ended Sept. 30, 2005.

Second-quarter net sales in the Fuller Brands segment rose 3 percent to $13.1 million from $12.7 million in last year's comparable period.

CPAC Inc. manages holdings in two industries. The Fuller Brands segment manufactures commercial, industrial and household cleaning products, as well as custom brushes and personal care lines. The CPAC Imaging segment develops and markets innovative Imaging chemicals, equipment and supplies at seven operations worldwide.